About Bio-Techne Corporation
https://www.bio-techne.comBio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics.
CEO
Kim Kelderman
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2022-11-30 | Forward | 4:1 |
| 2000-12-04 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 351
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 12
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:17.93M
Value:$1.23B
BLACKROCK INC.
Shares:14.99M
Value:$1.03B
BLACKROCK, INC.
Shares:11.89M
Value:$813.08M
Summary
Showing Top 3 of 724
About Bio-Techne Corporation
https://www.bio-techne.comBio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $286.56M ▼ | $139.4M ▼ | $38.18M ▲ | 13.32% ▲ | $0.25 ▲ | $77.8M ▲ |
| Q4-2025 | $316.96M ▲ | $222.67M ▲ | $-17.68M ▼ | -5.58% ▼ | $-0.11 ▼ | $6.43M ▼ |
| Q3-2025 | $316.18M ▲ | $175.85M ▲ | $22.59M ▼ | 7.14% ▼ | $0.14 ▼ | $67.85M ▼ |
| Q2-2025 | $297.03M ▲ | $146.47M ▲ | $34.89M ▲ | 11.75% ▲ | $0.22 ▲ | $72.11M ▲ |
| Q1-2025 | $289.46M | $143.03M | $33.6M | 11.61% | $0.21 | $70.48M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $144.96M ▼ | $2.53B ▼ | $560.33M ▼ | $1.97B ▲ |
| Q4-2025 | $162.19M ▲ | $2.56B ▼ | $639.06M ▲ | $1.92B ▼ |
| Q3-2025 | $140.67M ▼ | $2.64B ▼ | $626.23M ▲ | $2.02B ▼ |
| Q2-2025 | $177.55M ▼ | $2.67B ▼ | $591.93M ▼ | $2.08B ▼ |
| Q1-2025 | $187.54M | $2.74B | $597.37M | $2.14B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $38.19M ▲ | $27.59M ▼ | $605K ▲ | $-44.2M ▲ | $-17.22M ▼ | $22.22M ▼ |
| Q4-2025 | $-17.68M ▼ | $98.2M ▲ | $406K ▲ | $-90.45M ▼ | $21.52M ▲ | $93.31M ▲ |
| Q3-2025 | $22.59M ▼ | $41.12M ▼ | $-8.87M ▼ | $-68.05M ▲ | $-36.88M ▼ | $31M ▼ |
| Q2-2025 | $34.89M ▲ | $84.35M ▲ | $-5.03M ▲ | $-83.84M ▼ | $-9.99M ▼ | $77.53M ▲ |
| Q1-2025 | $33.6M | $63.89M | $-21.68M | $-11.57M | $35.75M | $54.72M |
Revenue by Products
| Product | Q2-2025 | Q4-2025 | Q3-2025 | Q1-2026 |
|---|---|---|---|---|
 Consumables | $230.00M ▲ | $250.00M ▲ | $260.00M ▲ | $230.00M ▼ |
 Instruments | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $20.00M ▼ |
 Royalty | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
 APAC excluding Greater China | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
 C N | $20.00M ▲ | $20.00M ▲ | $30.00M ▲ | $20.00M ▼ |
 Europe | $70.00M ▲ | $70.00M ▲ | $70.00M ▲ | $70.00M ▲ |
 Rest of World | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
 UNITED KINGDOM | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
 US | $160.00M ▲ | $180.00M ▲ | $180.00M ▲ | $160.00M ▼ |
CEO
Kim Kelderman
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2022-11-30 | Forward | 4:1 |
| 2000-12-04 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 351
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 12
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:17.93M
Value:$1.23B
BLACKROCK INC.
Shares:14.99M
Value:$1.03B
BLACKROCK, INC.
Shares:11.89M
Value:$813.08M
Summary
Showing Top 3 of 724